Vijay Martis analyses the growing “automation premium” in healthcare, where AI deployment can cost more than the clinicians it is intended to supplement.
Neurological diseases, including Parkinson’s and Alzheimer’s, continue to be a significant global health challenge. Progress has been hindered by a number of bottlenecks, despite considerable ...